Form 4 filed by Baranowski Lyn
Baranowski Lyn filed this Form 4 on AVLN (Avalyn Pharma Inc.) with 9 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-19 21:05:11 UTC.
- Accession
- 0001193125-26-468543
- Filer
- CIK 1893640
- Filed
- 2026-11-19
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: AVLN · Avalyn Pharma Inc. (CIK 1540171)
- Baranowski Lyn director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | M exercised | +45,300 | $4.62 | 45,300 | D |
| Common Stock | 2026-11-17 | S sold | -39,600 | $27.7604 | 5,700 | D |
| Common Stock | 2026-11-17 | S sold | -5,300 | $28.1514 | 400 | D |
| Common Stock | 2026-11-17 | S sold | -400 | $29.2249 | 0 | D |
| Common Stock | 2026-11-18 | M exercised | +7,200 | $4.62 | 7,200 | D |
| Common Stock | 2026-11-18 | S sold | -6,465 | $27.9049 | 735 | D |
| Common Stock | 2026-11-18 | S sold | -735 | $28.3643 | 0 | D |
| Stock Option (Right to Buy) derivative | 2026-11-17 | M exercised | -45,300 | $0 | 618,033 | D |
| Stock Option (Right to Buy) derivative | 2026-11-18 | M exercised | -7,200 | $0 | 610,833 | D |